Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

NCT05082233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Subjects Undergoing COH in ART to Prevent Early Ovulation

Interventions

DRUG: SHR7280 tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.